www.globalasthmareport.org Funded by The Union Global Asthma Report 2014 Designed for Government ministers Policy makers Health authorities Health professionals Patient organisations People living with asthma Global Asthma Report 2014: Headlines Asthma can be a terrible disease People with asthma struggle to breathe Asthma is a big cause of disability at all ages Asthma emergencies fill hospitals People can die 334 million people have asthma Global Asthma Report 2014: Headlines Asthma can be a terrible disease and there are effective essential asthma medicines and management programmes which can control asthma well and reduce the burden Global Asthma Report 2014: Headlines Economies suffer because of asthma Children miss school Adults can’t work Many adults don’t work effectively Serious loss of productivity Asthma costs are huge Europe €19 billion for 2011 USA $56 billion for 2007 These costs may be severely underestimated Global Asthma Report 2014: Headlines Economies suffer because of asthma and this can be changed by good asthma management available to all people with asthma Global Asthma Report 2014: Headlines Effective essential asthma medicines* aren’t reaching people Asthma inhalers are commonly o not manufactured properly o not available o too expensive *salbutamol (reliever) inhaled corticosteroids (preventer) Global Asthma Report 2014: Headlines Effective essential asthma medicines aren’t reaching people and this can be changed, so essential asthma inhalers are o quality-assured o available to all o affordable for all Global Asthma Report 2014: Headlines Asthma is seriously neglected other diseases ‘fashionable’ ‘invisible’ compared with obesity, stroke, cancer etc big gaps in asthma data no WHO monitoring programme scandal that economic burden is so high but attention is not being given Global Asthma Report 2014: Headlines Asthma is seriously neglected and this can be changed by higher awareness of asthma national asthma strategies standard case management more data and monitoring advocacy for change higher on national and global priorities Packed full with information and solutions 16 specific recommendations to WHO, governments, health authorities and health professionals Global Asthma Network: 280 centres in 120 countries The Global Asthma Network will close the data gaps will improve asthma management will continue advocacy www.globalasthmanetwork.org will reduce asthma suffering needs sustainable funding What happens in asthma? © GAN Global Asthma Report 2014: Contents Part One: The Burden of Asthma The Global Burden of Disease due to Asthma Hospital Admissions Due to Asthma Asthma Mortality Wheezing in infants The Economic Burden of Asthma Factors Affecting Asthma Prevalence of asthma symptoms in 13-14 year olds (ISAAC) 2000-2003 Prevalence of asthma symptoms in 18 to 45 year olds (WHO) 2002-2003 Burden of disease (disability adjusted life years DALYs) Asthma deaths all ages Global Asthma Report 2014: Headlines Asthma is made worse by Tobacco smoking Second-hand tobacco smoke Occupational exposures Global Asthma Report 2014: Contents Part Two: Management of Asthma and Capacity Building National Asthma Strategies (new survey results) Asthma Management Guidelines (new survey results) Access to Quality-Assured, Affordable Asthma Medicines (new survey results) Quality of Inhalers Asthma Management in Low-Income Countries Short Courses Relevant to Asthma Research and Policy Global Asthma Report 2014: Headlines Quality of asthma inhalers Asthma inhalers are complex devices which require accurate manufacturing Quality should never be compromised in the search for affordably-priced medicines Global Asthma Report 2014: Key Recommendation WHO and asthma inhalers add essential asthma medicines to their Prequalification Programme promote the standardisation of the dosages of active ingredients in combined inhalers harmonise quality requirements for inhalers across international reference documents such as the pharmacopoeias Global Asthma Report 2014: Headlines Access to quality-assured, affordable essential asthma medicines Quality-assured essential asthma medicines are not available to many people with asthma Many countries do not have them on national reimbursement lists or essential medicines lists Guaranteed access to these medicines is vital to improving asthma outcomes Global Asthma Report 2014: Contents Part Three: Asthma – a Global Priority Asthma as a Lung Health Priority in Low- and Middle-Income Countries Asthma as an NCD Priority Global Asthma Report 2014: Headlines Access to asthma care Reduce under-diagnosis of asthma Asthma education Standard case management Global Asthma Report 2014: Headlines Asthma is a hugely neglected public health and ‘development’ problem in the world which could be solved Political commitment and action are required urgently Asthma medicines need to be affordable Raise awareness and priority of asthma More data are needed